Table 1 RAD51 protein expression in GBM tumors. M Male, F Female, OS Overall survival, PFS Progression-free survival
From: A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells
Number of case | Median age (range) | Gender | Median PFS (range; months) | OS median (range; months) | ||
|---|---|---|---|---|---|---|
F | M | |||||
RAD51 + | 26 | 63 (39–76) | 10 | 16 | 6.8 (2.9–25.6) | 14.1 (5.3–70.1) |
RAD51 - | 43 | 60 (32–83) | 11 | 32 | 8.5 (2–41.8) | 18.5 (3.1–45.4) |